✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals
Market Cap
₹1,836 Cr.
P/E
35.93

Key Ratios

Market cap
Market cap
1,836 Cr
PE
PE
35.93
Prom Holding
Prom Holding
67.28 %
ROE (%)
ROE (%)
10.61
ROCE (%)
ROCE (%)
11.17
Div Yield (%)
Div Yield (%)
2.69
Sales
Sales
214 Cr
OPM (%)
OPM (%)
30.46 %
Debt to Equity
Debt to Equity
0.05

About

Paushak Ltd is engaged in the manufacture of Phosgene & its derivatives.Phosgene is a versatil… Read more
Low
468
52W Range
High
991
  • Paushak
  • Atul
  • Hikal
  • TJI Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Manufacturing Capacity - Speciality Chemicals (MTPA)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Paushak Ltd. Business

    Paushak Ltd specializes in manufacturing Phosgene and its derivatives, which are used in various industries such as pharmaceuticals, agrochemicals, polyurethanes, perfumeries, and dyes. Their product range includes Isocyanates, Chloroformates, Carbamoyl Chlorides, Urea, and more.

    Paushak major competitors are Atul, Hikal, Ultramar & Pigments, Chemcon Speciality, Tatva Chintan Pharma, Valiant Organics, DMCC Speciality Chem.
    Market Cap of Paushak is ₹1,847 Crs.
    While the median market cap of its peers are ₹1,309 Crs.

    Paushak seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material